Novo Nordisk has a total of 9089 patents globally, out of which 3631 have been granted. Of these 9089 patents, more than 42.25% patents are active. Novo Nordisk has filed the maximum number of patents in the United States of America, followed by Europe (EPO) and China. In line with this, Europe (EPO) also serves as Novo Nordisk’s primary R&D focus area.
Novo Nordisk, established in 1923, is a leading global pharmaceutical company with a strong focus on innovative research and development. The company specializes in the discovery, development, manufacturing, and commercialization of biologic medicines and advanced healthcare solutions.
Its diverse portfolio spans key therapeutic areas, including diabetes care, obesity management, cardiovascular diseases, and rare diseases such as hemophilia and growth disorders. With a heritage of more than a century and a deep commitment to scientific innovation, Novo Nordisk plays a vital role in improving patient outcomes and expanding access to high-quality, life-changing treatments worldwide.
Do read about some of the most popular patents of Nova Nordisk which have been covered by us in this article and also you can find Nova Nordisk patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nova Nordisk patent portfolio.
How many patents does Nova Nordisk have?
Nova Nordisk has a total of 9089 patents globally. These patents belong to 2998 unique patent families. Out of 9089 patents, 3841patents are active.
Take a look over the full story behind Nova Nordisk lost patents – expired patents, legal battles, and product drops – click here and explore the insights.
How Many Patents did Nova Nordisk File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Nova Nordisk Applications Filed | Nova Nordisk Patents Granted |
| 2025 | 107 | 164 |
| 2024 | 196 | 213 |
| 2023 | 339 | 204 |
| 2022 | 299 | 207 |
| 2021 | 407 | 243 |
| 2020 | 481 | 348 |
| 2019 | 445 | 283 |
| 2018 | 540 | 269 |
| 2017 | 502 | 243 |
| 2016 | 444 | 210 |
How many Nova Nordisk patents are Alive/Dead?
Worldwide Patents
How Many Patents did Nova Nordisk File in Different Countries?
Countries in which Nova Nordisk Filed Patents
| Country | Patent |
| United States Of America | 1511 |
| Europe (EPO) | 1097 |
| China | 944 |
| Japan | 933 |
| India | 288 |
| Australia | 258 |
| Canada | 215 |
| Brazil | 211 |
| South Korea | 200 |
| Spain | 168 |
| Russia | 156 |
| Mexico | 145 |
| Israel | 141 |
| Taiwan | 131 |
| South Africa | 123 |
| Poland | 92 |
| Denmark | 82 |
| Tunisia | 82 |
| Turkey | 75 |
| Morocco | 73 |
| Malaysia | 73 |
| Hong Kong (S.A.R.) | 60 |
| Argentina | 59 |
| Indonesia | 56 |
| Hungary | 55 |
| Ireland | 55 |
| Singapore | 50 |
| Portugal | 48 |
| Philippines | 44 |
| Colombia | 44 |
| Viet Nam | 42 |
| Austria | 40 |
| Serbia | 39 |
| Croatia | 38 |
| Saudi Arabia | 34 |
| Eurasia | 33 |
| Bulgaria | 29 |
| Slovenia | 27 |
| Germany | 27 |
| Thailand | 25 |
| Chile | 19 |
| Norway | 18 |
| Romania | 14 |
| New Zealand | 8 |
| Iran | 8 |
| Netherlands | 5 |
| Latvia | 5 |
| Lithuania | 5 |
| France | 3 |
| Gulf Cooperation Council | 2 |
| Africa | 2 |
| Costa Rica | 2 |
| Finland | 2 |
| Luxembourg | 1 |
| Switzerland | 1 |
| Ukraine | 1 |
Where are Research Centres of Nova Nordisk Patents Located?
10 Best Nova Nordisk Patents
US8574199B2 is the most popular patent in the Nova Nordisk portfolio. It has received 1168 citations so far from companies like Ethicon Endo-Surgery, Cilag and Sanofi.
Below is the list of 10 most cited patents of Nova Nordisk:
| Publication Number | Citation Count |
| US8574199B2 | 1168 |
| US20090182127A1 | 694 |
| US20070179352A1 | 543 |
| US20060253296A1 | 362 |
| US20070049873A1 | 359 |
| US20090247931A1 | 296 |
| US20060069382A1 | 279 |
| WO2006040329A1 | 266 |
| US20100063438A1 | 242 |
| US20080215006A1 | 215 |
What Percentage of Nova Nordisk US Patent Applications Were Granted?
Nova Nordisk (Excluding its subsidiaries) has filed 3386 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2061 have been granted leading to a grant rate of 64.15%.
Below are the key stats of Nova Nordisk patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Nova Nordisk?
| Law Firm | Total Applications | Success Rate |
| Novo Nordisk Inc (Inhouse IP Deptt) | 1836 | 76.80% |
| Novozymes North America Inc | 868 | 75.75% |
| Blank Rome Llp | 172 | 81.33% |
| Leydig Voit & Mayer Ltd | 85 | 48.24% |
| High Point Pharmaceuticals Llc | 67 | 58.21% |
| Gordon W Hueschen | 49 | 97.96% |
| Epa Bozicevic Field & Francis Llp | 34 | 70.59% |
| Reza Green | 24 | 37.50% |
| Fidelman & Wolffe | 23 | 79.13% |
| Darby & Darby | 21 | 91.67% |
EXCLUSIVE INSIGHTS COMING SOON!